Background and Purpose-We evaluated the impact that duration as a primary stroke center (PSC) had on tissue-type plasminogen activator (tPA) utilization for acute ischemic stroke. Methods-A retrospective analysis of the Illinois Hospital Association CompData was performed identifying those patients with primary discharge diagnosis of acute ischemic stroke based on International Classification of Diseases version 9 codes. We assessed utilization of tPA by International Classification of Diseases version 9 procedure code (99.10). We categorized patients as cared for at non-PSC, PSC Ͼ1 year before, Յ1 year before, Յ1 year after, and Ͼ1 year after certification. We used generalized estimating equations to calculate adjusted odds ratios for tPA utilization by PSC category. Results-Among 119 539 acute ischemic stroke patients (mean age, 72 years; 55.2% women), tPA use was 1.9% but increased by PSC category (PϽ0.001): (1) non-PSC 0.9%; (2) Ͼ1 year before PSC certification 1.4%; (3) Յ1 year before certification 3.2%; (4) Յ1 year after certification 4.3%; and (5) Ͼ1 year after certification 6.5%. Adjusting for age, insurance status, admission source, year of study, region of Illinois, and hospital bed size, the odds of tPA utilization increased with advancing stage of PSC certification (highest category: adjusted odds ratio, 2.37; 95% confidence interval, 1.52-3.71). Conclusions-Although increasing over time, stroke thrombolysis is strongly impacted by the PSC certification process.
I
ntravenous tissue-type plasminogen activator (tPA) utilization for acute ischemic stroke remains low nationwide. 1, 2 The establishment of stroke systems of care including primary stroke centers (PSC) is expected to increase tPA utilization and improve outcomes after stroke. 3, 4 A previous study 5 noted that performance improvement may be evident even in advance of PSC certification. However, it is not known whether PSC continue to increase tPA use over time, or whether there is an immediate effect with a subsequent plateau or decline. We hypothesized that utilization of tPA increases with duration of time as a certified PSC.
Materials and Methods
With institutional board review, a retrospective analysis of the Illinois Hospital Association COMPdata was performed. The Illinois Hospital Association includes Ͼ200 hospitals and health systems within the state. The available patient level data (Table 1) are typical of administrative databases but do not contain stroke-specific variables such as time of onset, severity (ie, National Institutes of Health Stroke Severity score), imaging results, or complications of therapy.
In addition, we used the Joint Commission Web site (accessed September 14, 2010; http://www.qualitycheck.org/consumer/searchQCR.aspx) to determine date of initial PSC certification. For 2 hospitals that were not certified by the Joint Commission, we obtained date of PSC certification directly from the institutions. We categorized each patient as having been cared for at non-PSC hospitals (as of September 2010, 1 year after the study period), hospitals Ͼ1 year before PSC certification, Յ1 year before PSC certification, Յ1 year after PSC certification, and Ͼ1 year after PSC certification.
From procedure code (99.10). We performed trend analyses, univariable tests, and a multivariable analysis using a general estimating equations approach to assess the impact of PSC certification on tPA utilization. All analyses were performed in SAS 9.1 (SAS Institute). (8), and Southern (1). Care was provided at PSC in 14.7% of patients during the study period.
Results

Between
Overall, the proportion of tPA use was 5.7% among acute ischemic stroke patients treated at PSC, compared to 1.2% at non-PSC (PϽ0.001), but with differing temporal trends ( Figure A) . Within the categories of PSC status, there was a strong relationship (PϽ0.001) between increasing tPA use and hospital-specific time epoch along the PSC certification process ( Figure B) . In multivariable analysis (Table 2) , the odds of tPA use increased with advancing PSC status.
Discussion
Although increasing over time, stroke thrombolysis is strongly impacted by the PSC certification process. Rather than waning or stagnating, PSC increase tPA utilization from the earliest phases of preparation through certification and subsequent maintenance. These results add to previous reports that PSC show improvements in performance metrics, such as tPA utilization, 6, 7 and outcomes even before formal certification. 5 The efforts to initiate and maintain certification often require significant planning, quality-improvement initiatives, data collection, protocol development, and education well in advance of and after certification. The temporal increase in tPA use at non-PSC that we observed also may be partly explained as an effect of PSC certification process initiation at some centers that later became PSC.
There are several limitations to our study, including reliance on International Classification of Diseases version 9 codes. 2 Because the registry consists of hospitalized patients, we also cannot identify "drip and ship" tPA patients, which might underestimate non-PSC tPA utilization. We cannot account for important eligibility criteria such as time of onset, severity of symptoms, or imaging findings. The impact of prehospital notification or triage of eligible patients to PSC 8 -11 could not account for our results. Illinois House Bill 2244, advocating for the development of PSC and improving access to them, passed in August 2009. Our findings, therefore, reflect the utilization of tPA before the implementation of prehospital routing policies in Illinois. However, we cannot exclude the possibility that PSC certification promoted local community education and informal emergency medical service preferences to take eligible patients to PSC.
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Figure.
Tissue-type plasminogen activator (tPA) utilization (A) increased at nonprimary stroke centers (PϽ0.001) but was unchanged at primary stroke centers annually (Pϭ0.371) and (B) increased with each stage along the primary stroke center process (PϽ0.001). PSC indicates primary stroke center.
